EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
July 31, 2026 0.0141
April 30, 2026 0.0875
January 31, 2026 0.0269
October 31, 2025 0.0473
July 31, 2025 0.0417
April 30, 2025 -0.0677
January 31, 2025 -0.0373
October 31, 2024 -0.0013
July 31, 2024 -0.0586
April 30, 2024 0.0369
January 31, 2024 -0.049
October 31, 2023 -0.0142
July 31, 2023 0.0009
April 30, 2023 -0.0431
January 31, 2023 -0.2035
October 31, 2022 0.017
July 31, 2022 -0.0694
April 30, 2022 0.0373
January 31, 2022 -0.133
October 31, 2021 -0.0818
July 31, 2021 -0.1597
April 30, 2021 -0.0956
January 31, 2021 -0.1106
October 31, 2020 -0.1578
July 31, 2020 -0.1042
Date Value
April 30, 2020 -0.2804
January 31, 2020 -0.202
October 31, 2019 -0.2001
July 31, 2019 -0.2693
April 30, 2019 -0.2117
January 31, 2019 -0.2174
October 31, 2018 -0.212
July 31, 2018 -0.2361
April 30, 2018 -0.2274
January 31, 2018 -0.19
October 31, 2017 -0.1693
July 31, 2017 -0.1456
April 30, 2017 -0.0534
January 31, 2017 -0.1387
October 31, 2016 -0.1708
July 31, 2016 -0.2402
April 30, 2016 -0.221
January 31, 2016 -0.3823
October 31, 2015 -0.184
July 31, 2015 -0.1721
April 30, 2015 -0.1592
January 31, 2015 -0.1747
October 31, 2014 -0.2283
July 31, 2014 -0.3082
April 30, 2014 -0.2296

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Healios KK 0.0554
GNI Group Ltd. 0.0156
AnGes, Inc. -0.0258
ACADIA Pharmaceuticals, Inc. 0.1822
Alkermes Plc 0.0029